These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 24056707

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. NFAT2 is an essential mediator of orthopedic particle-induced osteoclastogenesis.
    Yamanaka Y, Abu-Amer W, Foglia D, Otero J, Clohisy JC, Abu-Amer Y.
    J Orthop Res; 2008 Dec; 26(12):1577-84. PubMed ID: 18655139
    [Abstract] [Full Text] [Related]

  • 4. Pentamidine Inhibits Titanium Particle-Induced Osteolysis In Vivo and Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation In Vitro.
    Ihn HJ, Kim K, Cho HS, Park EK.
    Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
    [Abstract] [Full Text] [Related]

  • 5. Blockade of JNK and NFAT pathways attenuates orthopedic particle-stimulated osteoclastogenesis of human osteoclast precursors and murine calvarial osteolysis.
    Yamanaka Y, Clohisy JC, Ito H, Matsuno T, Abu-Amer Y.
    J Orthop Res; 2013 Jan; 31(1):67-72. PubMed ID: 22847537
    [Abstract] [Full Text] [Related]

  • 6. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G, Wang FF, Li T, Jia DD, Shen Y, Xu HC.
    Med Sci Monit; 2018 Apr 26; 24():2569-2577. PubMed ID: 29698379
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
    Jules J, Zhang P, Ashley JW, Wei S, Shi Z, Liu J, Michalek SM, Feng X.
    J Biol Chem; 2012 May 04; 287(19):15728-38. PubMed ID: 22416138
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.
    J Bone Miner Res; 2005 Apr 04; 20(4):653-62. PubMed ID: 15765185
    [Abstract] [Full Text] [Related]

  • 13. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS, Oh J.
    Bone; 2015 Oct 04; 79():242-51. PubMed ID: 26103094
    [Abstract] [Full Text] [Related]

  • 14. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
    Zhang L, Yang Y, Liao Z, Liu Q, Lei X, Li M, Saijilafu, Zhang Z, Hong D, Zhu M, Li B, Yang H, Chen J.
    Theranostics; 2020 Oct 04; 10(15):6638-6660. PubMed ID: 32550895
    [Abstract] [Full Text] [Related]

  • 15. Titanium particle‑mediated osteoclastogenesis may be attenuated via bidirectional ephrin‑B2/eph‑B4 signaling in vitro.
    Ge YW, Liu ZQ, Sun ZY, Yu DG, Feng K, Zhu ZA, Mao YQ.
    Int J Mol Med; 2018 Oct 04; 42(4):2031-2041. PubMed ID: 30015911
    [Abstract] [Full Text] [Related]

  • 16. Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
    Son A, Kang N, Oh SY, Kim KW, Muallem S, Yang YM, Shin DM.
    J Endocrinol; 2019 Sep 04; 242(3):241-249. PubMed ID: 31319381
    [Abstract] [Full Text] [Related]

  • 17. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z, Chai H, Wang S, Sun C, Huang Q, Xu W.
    J Mol Med (Berl); 2023 May 04; 101(5):607-620. PubMed ID: 37121919
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nuclear presence of nuclear factor of activated T cells (NFAT) c3 and c4 is required for Toll-like receptor-activated innate inflammatory response of monocytes/macrophages.
    Minematsu H, Shin MJ, Celil Aydemir AB, Kim KO, Nizami SA, Chung GJ, Lee FY.
    Cell Signal; 2011 Nov 04; 23(11):1785-93. PubMed ID: 21726630
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca2+ -calcineurin-NFATc1 pathway.
    Cao B, Dai X, Wang W.
    J Cell Physiol; 2019 May 04; 234(5):6831-6841. PubMed ID: 30387123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.